The 36 Factors Contributing to Cognitive Decline You Should Know About

Most people think of Alzheimer’s as a single disease with a single cause. Dr. Dale Bredesen‘s research tells a different story — one where cognitive decline results from a unique combination of more than 36 individual contributors, from chronic inflammation and hormone deficiencies to toxin exposure and metabolic dysfunction.

This multi-factorial reality explains why over 400 clinical drug trials have failed to produce lasting solutions. Below, we break down all 36 factors, the six subtypes they fall into, and how comprehensive testing can identify which ones are affecting you or your loved one.

Michigan Cognitive Recovery Center at Lakeshore Woods is one of only two senior living centers in the United States that offers the ReCODE+ For Facilities Program — a clinically validated, precision-medicine approach developed by Dr. Bredesen through Apollo Health — and we use this 36-factor framework as the foundation of every resident’s personalized care plan.

Key Takeaways

• Cognitive decline results from multiple overlapping contributors — not a single cause — which helps explain why single-drug treatments have shown limited success.
• Dr. Dale Bredesen — neurologist, Chief Scientific Officer at Apollo Health, and author of The End of Alzheimer’s Program and Ageless Brain — identified more than 36 specific biochemical factors that can contribute to memory loss and cognitive impairment.
• The 36 factors cluster into six main subtypes: inflammatory, atrophic, glycotoxic, toxic, vascular, and traumatic.
• Each person has a unique combination of contributing factors, making personalized testing essential for effective intervention.
• Published clinical studies show 84% of participants improved cognition in the first ReCODE clinical trial, and 90% improved in the 2025 Randomized Controlled Trial, per Apollo Health.
• Early identification — particularly during subjective cognitive impairment (SCI) or mild cognitive impairment (MCI) — offers the greatest opportunity for intervention.

What cognitive decline is and why it is multi-factorial

Cognitive decline refers to a gradual reduction in mental abilities like memory, reasoning, attention, and processing speed. Some slowing is normal with age, but more significant changes can signal underlying problems worth investigating.

For decades, conventional medicine treated Alzheimer’s and related conditions as single diseases with single causes. Yet over 400 clinical drug trials targeting one mechanism have failed to produce lasting solutions. For a clear comparison of conventional and precision medicine approaches, see our article: Functional Medicine vs. Traditional Alzheimer’s Care: What Families Need to Know.

The reason single-drug approaches fall short? Cognitive decline isn’t driven by one factor — it’s the result of many contributors working together. Dr. Dale Bredesen’s research through Apollo Health identified more than 36 individual biochemical contributors to cognitive decline, ranging from chronic inflammation and hormonal imbalances to toxin exposure and nutrient deficiencies.

Common early signs to be aware of include:

• Memory changes: Difficulty recalling recent events, names, or conversations
• Processing speed: Taking longer to complete familiar mental tasks
• Executive function: Trouble with planning, organizing, or making decisions

Normal aging vs. mild cognitive impairment vs. early Alzheimer’s

Not all memory changes indicate disease. Knowing where you or your loved one falls on the spectrum helps determine which interventions make the most sense. For a deeper look at timing and the intervention window, see: Early Stage Alzheimer’s: Why Timing Matters More Than Severity.

Stage	Characteristics	Intervention Opportunity
Normal aging	Occasional forgetfulness, slower recall, but daily function intact	Prevention and optimization
Mild cognitive impairment (MCI)	Noticeable memory or thinking problems beyond normal aging, but independence maintained	Highest opportunity for factor identification and intervention
Early Alzheimer’s	Progressive decline affecting daily activities, requiring some assistance	Intervention still possible, though outcomes vary

The 36-factor framework applies most powerfully during SCI and MCI stages, when the brain still has significant capacity for neuroplasticity — the brain’s ability to form new neural connections and adapt.

Where the 36-factor framework comes from

Dr. Dale Bredesen — neurologist, Chief Scientific Officer at Apollo Health, and author of The End of Alzheimer’s Program and Ageless Brain — spent over 30 years researching the mechanisms behind Alzheimer’s disease. His work, published in peer-reviewed journals, challenged the conventional single-cause model.

Through Apollo Health, Dr. Bredesen developed the ReCODE protocol — a precision medicine approach that identifies and addresses each person’s unique combination of contributing factors. Precision medicine means treatment tailored to an individual’s specific biochemistry, genetics, and exposures rather than a one-size-fits-all approach.

Clinical results from Apollo Health’s published research are striking: 84% of participants improved cognition in the first clinical trial of the ReCODE program. In the 2025 Randomized Controlled Trial — the first of its kind — 90% of participants improved, with an effect size 600% greater than the leading FDA-approved Alzheimer’s drug. Participants also showed improved blood pressure, insulin sensitivity, and cholesterol levels. (Source: Apollo Health)

The six subtypes of cognitive decline identified by Dr. Bredesen

The 36 factors don’t exist in isolation. Instead, they cluster into six main subtypes, each with a dominant driver. Many people have features of multiple subtypes, which is why comprehensive testing matters.

Inflammatory type

The inflammatory subtype is driven by chronic inflammation from sources like infections, gut dysfunction, or immune system overactivity. People with this type often show elevated inflammatory markers in blood tests. Common contributors include chronic sinus infections, periodontal disease, and intestinal permeability (sometimes called “leaky gut”). To learn more about why medication-only approaches miss these drivers, see: Why Medication Alone Is Not Enough for Alzheimer’s Care.

Atrophic type

The atrophic subtype results from a lack of supportive factors the brain requires to maintain itself. Think of it as the brain “withdrawing support” from neurons. Hormone deficiencies, low nerve growth factors, and inadequate nutrients characterize this type.

Glycotoxic type

Sometimes called Type 1.5, the glycotoxic subtype combines inflammation with insulin resistance and glucose dysregulation. It’s increasingly common given rising rates of metabolic syndrome and prediabetes. Blood sugar instability directly damages brain cells over time.

Toxic type

Exposure to metals, mold, mycotoxins, or organic chemicals drives the toxic subtype. It’s often overlooked in conventional evaluations because standard testing doesn’t screen for toxic exposures. People with toxic-type decline may have lived or worked in water-damaged buildings or had occupational chemical exposure.

Vascular type

Cardiovascular problems affecting blood flow to the brain characterize the vascular subtype. Hypertension, atherosclerosis, and small vessel disease reduce oxygen and nutrient delivery to brain tissue. Sleep apnea also falls into this category due to repeated nighttime oxygen drops.

Traumatic type

Head injuries — even seemingly minor ones — can contribute to cognitive decline years later. The traumatic subtype includes both single significant injuries and cumulative damage from repeated impacts. Structural issues affecting blood flow, such as cervical spine problems, also belong here.

The 36 factors contributing to cognitive decline

Now let’s look at the specific factors within each category. Each of the 36 factors can be tested and, in many cases, addressed through targeted interventions.

Genetic and family history contributors

• APOE4 gene status: Carrying one or two copies of the APOE4 gene variant increases Alzheimer’s risk, though it’s not destiny — lifestyle factors can modify this risk.
• Family history of dementia: Having a parent or sibling with Alzheimer’s increases statistical risk and suggests shared genetic or environmental factors.
• MTHFR and methylation genes: Variants affecting how the body processes B vitamins and detoxifies can contribute to elevated homocysteine and impaired cellular repair.
• Presenilin genes (PSEN1, PSEN2): Rare mutations causing early-onset familial Alzheimer’s, typically appearing before age 65.

Inflammatory and immune contributors

Chronic inflammation acts like a slow burn in the brain, damaging neurons over time. The sources of inflammation vary widely from person to person.

• Chronic infections: Oral bacteria, sinus infections, gut pathogens, and tick-borne illnesses like Lyme disease can trigger ongoing brain inflammation.
• Elevated inflammatory markers: High-sensitivity C-reactive protein (hs-CRP) and homocysteine levels indicate systemic inflammation affecting the brain.
• Gut permeability: When the intestinal lining becomes too permeable, inflammatory compounds enter the bloodstream and can cross into brain tissue.
• Autoimmune activity: The immune system attacking the body’s own tissues can include brain-reactive antibodies.
• Gluten sensitivity: Even without celiac disease, gluten can trigger inflammation in sensitive individuals.

Metabolic and insulin-related contributors

The brain uses more energy than any other organ, so metabolic problems hit it hard. Insulin resistance in particular has become so linked to cognitive decline that some researchers call Alzheimer’s “Type 3 diabetes.”

• Insulin resistance: When cells stop responding properly to insulin, glucose metabolism in the brain suffers.
• Fasting glucose dysregulation: Blood sugar levels outside optimal ranges damage neurons over time.
• Hemoglobin A1c elevation: This marker of average blood sugar over three months predicts cognitive risk even in non-diabetics.
• Metabolic syndrome markers: The combination of abdominal obesity, high triglycerides, low HDL, and elevated blood pressure compounds brain risk.
• Mitochondrial dysfunction: When cellular energy production falters, brain cells — which require enormous energy — suffer first.

Hormonal and nutrient deficiency contributors

The brain depends on a steady supply of hormones and nutrients to function properly. Deficiencies in any of the following can contribute to cognitive decline:

• Thyroid dysfunction: Both low and high thyroid function affect cognition, memory, and processing speed.
• Low vitamin D: This hormone-like vitamin supports brain cell growth and immune regulation.
• B vitamin deficiencies: B12, folate, and B6 are essential for nerve function and homocysteine metabolism.
• Hormone imbalances: Estrogen, testosterone, pregnenolone, and DHEA all support brain health.
• Omega-3 fatty acid insufficiency: Omega-3s form brain cell membranes and reduce inflammation.
• Zinc and copper imbalance: The ratio between zinc and copper matters as much as absolute levels.
• Magnesium deficiency: Magnesium supports hundreds of enzymatic reactions including those critical for brain function.

Toxic and environmental contributors

Toxins accumulate in the body over years, often without obvious symptoms until cognitive changes appear.

• Heavy metals: Mercury from dental amalgams or fish, lead from old paint or pipes, and arsenic from water contaminate many people unknowingly.
• Mold and mycotoxin exposure: Water-damaged buildings produce toxins that can cross the blood-brain barrier and trigger inflammation.
• Organic pollutants and pesticides: Accumulated exposure to chemicals in food, water, and air contributes to toxic burden.
• Air quality and particulate matter: Fine particles from pollution can enter the brain through the nasal passages.

Vascular and cardiovascular contributors

What’s good for the heart is good for the brain. Vascular problems reduce blood flow, starving brain cells of oxygen and nutrients.

• Hypertension: High blood pressure damages small blood vessels throughout the brain over time.
• Hyperlipidemia: Abnormal cholesterol and triglyceride levels contribute to atherosclerosis affecting cerebral circulation.
• Reduced cerebral blood flow: Any condition limiting blood delivery to the brain starves neurons.
• Sleep apnea and nocturnal hypoxia: Repeated oxygen drops during sleep cause cumulative brain damage.
• Atrial fibrillation: Irregular heart rhythm increases stroke risk and reduces consistent brain perfusion.

Structural and traumatic contributors

• History of head trauma or concussion: Even “mild” injuries can trigger long-term inflammatory cascades.
• Cervical spine issues: Neck problems can compress arteries supplying the brain.
• Reduced brain-derived neurotrophic factor (BDNF): BDNF is a protein that supports neuron growth and survival; low levels impair brain resilience.

Lifestyle and behavioral contributors

Daily habits have a profound impact on brain health. The following lifestyle factors appear repeatedly in cognitive decline research. For practical guidance on lifestyle-based intervention, see: Lifestyle Changes That Improve Brain Health and Reduce Alzheimer’s Risk.

• Sleep quality and duration: Deep sleep is when the brain clears toxic proteins; poor sleep accelerates decline.
• Chronic stress and elevated cortisol: Prolonged stress hormones damage the hippocampus, the brain’s memory center.
• Sedentary behavior: Physical inactivity reduces blood flow, BDNF production, and metabolic health.
• Social isolation: Loneliness and limited social engagement are independent risk factors for cognitive decline.
• Diet quality and timing: What and when you eat affects inflammation, insulin sensitivity, and brain energy.
• Alcohol and substance use: Excessive consumption directly damages brain tissue and depletes nutrients.

How to identify which factors are affecting you

Knowing the 36 factors exist is only the first step. The real question is: which ones are affecting you or your loved one? Identifying individual factors requires comprehensive testing that goes beyond standard medical evaluations.

1. Complete a comprehensive cognitive assessment

Cognitive testing establishes a baseline of current function across multiple domains — memory, attention, processing speed, and executive function. Tools like the Montreal Cognitive Assessment (MoCA) or computerized testing reveal which areas are affected and how severely.

2. Run functional lab and biomarker testing

Comprehensive blood panels go far beyond standard annual checkups. Functional lab testing includes inflammatory markers, metabolic indicators, nutrient levels, hormone panels, and immune markers. This type of testing reveals hidden contributors that conventional evaluations often miss.

3. Screen for genetic risk and toxin exposure

Genetic testing identifies APOE4 status and other relevant variants. Mycotoxin panels detect mold exposure. Heavy metal testing reveals accumulated toxic burden. Genetic and toxin screenings uncover factors that lifestyle changes alone won’t address.

4. Build a personalized ReCODE Report™

Apollo Health’s precision medicine platform synthesizes all test results into an individualized report. The ReCODE Report™ identifies which of the 36 factors are present, ranks them by importance, and guides a personalized intervention plan.

How a precision medicine approach addresses each factor

Once testing identifies an individual’s contributing factors, targeted interventions address each one. The Bredesen Seven represent complementary strategies that work together to support cognitive recovery:

1. KetoFLEX 12/3 nutrition: Apollo Health’s KetoFLEX 12/3 — a plant-rich, mildly ketogenic diet with a 12-hour overnight fast — supports brain energy and reduces inflammation.
2. Exercise: Both aerobic activity and strength training increase blood flow and BDNF production.
3. Sleep optimization: Addressing sleep apnea, improving sleep hygiene, and ensuring adequate deep sleep allows the brain to clear toxins.
4. Stress management: Meditation, breathing practices, and lifestyle modifications lower cortisol and protect the hippocampus.
5. Brain stimulation: Structured brain exercises and novel learning experiences promote neuroplasticity.
6. Detoxification: Gentle protocols help the body eliminate accumulated toxins identified through testing.
7. Targeted supplements: Based on individual deficiencies and genetic variants, targeted nutrients fill specific gaps.

A residential program can implement all seven strategies simultaneously with 24/7 support — something that’s difficult for families to replicate at home while managing daily life. At Michigan Cognitive Recovery Center, the 12-month ReCODE+ Residential Program begins with comprehensive testing to identify each resident’s specific contributors, then delivers personalized interventions with round-the-clock support inside Lakeshore Woods Senior Living‘s Birch Building in Fort Gratiot, Michigan.

Take the next step toward cognitive recovery in Michigan

Michigan Cognitive Recovery Center at Lakeshore Woods Senior Living is one of only two senior living centers in the United States that offers the ReCODE+ For Facilities Program — implementing Dr. Bredesen’s protocol in a full residential setting in partnership with Apollo Health. The program is best suited for individuals with subjective cognitive impairment, mild cognitive impairment, or early-stage Alzheimer’s disease. We don’t claim to cure Alzheimer’s — we offer a comprehensive, evidence-based approach that has shown measurable outcomes in published peer-reviewed studies, per Apollo Health. 📞 Call (810) 385-3185 or book a tour to learn how the 36-factor framework could apply to your family’s situation.

Frequently asked questions about the 36 factors of cognitive decline

Disclaimer: This content is for educational purposes only and does not constitute medical advice. Treatment decisions should always be made with a qualified healthcare provider who knows the patient. The ReCODE Protocol is a precision-medicine program delivered by Apollo Health-trained practitioners and is not a cure for Alzheimer’s disease. Outcomes vary by individual. For complete clinical information, please visit Apollo Health.

About the author. This article was written by the Lakeshore Woods Team. Lakeshore Woods Senior Living is a 78-bed senior living community in Fort Gratiot Township, Michigan, and the home of Michigan Cognitive Recovery Center — one of only two U.S. senior living centers that offers the ReCODE+ For Facilities Program in partnership with Apollo Health. For complete clinical information, please visit Apollo Health.